Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kamitamari

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2001
[Transitional pre-B-cell ALL]C Yun, A Kamitamari, M Okada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1997
[Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)]M Tsurusawa, N Katano, T Hirota, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 10, 1998
[Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group]T Hirota, T Fujimoto, N Katano, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 3, 2001
[Transitional pre-B-cell ALL]C Yun, A Kamitamari, M Okada, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 1, 1997
[Treatment results in childhood acute myeloblastic leukemia--a report of clinical trials of a past decade from the Japanese children's Cancer and Leukemia Study Group (CCLSG)]M Tsurusawa, N Katano, T Hirota, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 10, 1998
[Treatment results of intermittent and cyclic regimen with ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group]T Hirota, T Fujimoto, N Katano, et al.
Pageof 1